June 14 (Reuters) - The U.S. Food and Drug
Administration recommended COVID-19 vaccine makers target the
KP.2 strain with the updated shots, if feasible, changing its
earlier advisory seeking targeting of the JN.1 variant, which
was dominant earlier this year.